Medicare Enrolled
Dr. Scott Schafrank, M.D.
Optician · Wayne, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Schafrank from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schafrank?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Schafrank
Dr. Scott Schafrank is an optician specialist in Wayne, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Schafrank performed 13,514 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Schafrank received a total of $7,531 from 41 pharmaceutical and/or device companies across 381 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Schafrank is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 2% volume in PA
$7,531 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗13,514
Medicare services
Top 2% in PA for optician
Not available
Unique patients (not deduplicated)
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
4,650 | $6 | $11 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
1,782 | $36 | $108 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
1,771 | $71 | $164 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,198 | $65 | $143 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,123 | $94 | $202 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
920 | $43 | $81 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
556 | $87 | $184 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
298 | $127 | $288 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
234 | $42 | $90 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
169 | $252 | $491 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
110 | $74 | $278 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
95 | $93 | $202 |
| Surgical removal of facial skin cancer, 1.1-2.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the removed tissue is between 1.1 and 2.0 centimeters. |
82 | $118 | $431 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 79 | $261 | $510 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
57 | $1 | $2 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
45 | $72 | $178 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 42 | $142 | $304 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
39 | $120 | $449 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
36 | $68 | $156 |
| Lip biopsy A procedure to remove a small sample of tissue from the lip for laboratory examination. |
30 | $90 | $197 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
28 | $103 | $204 |
| Destruction of cancerous skin growth, 2.1-3.0 cm This procedure involves the removal or destruction of a cancerous skin lesion measuring between 2.1 and 3.0 centimeters located on the trunk, arms, or legs. |
25 | $149 | $311 |
| Intermediate wound repair, 2.6-7.5 cm This procedure involves stitching a wound on the neck, hands, feet, or genitals that measures between 2.6 and 7.5 centimeters. It is classified as an intermediate repair requiring layered closure. |
22 | $248 | $500 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
22 | $125 | $273 |
| Skin cancer removal, face/ears/eyes/nose/lips, 2.1-3.0 cm Surgical removal of a cancerous skin growth from the face, ears, eyelids, nose, lips, or mouth. The procedure involves excising a lesion measuring between 2.1 and 3.0 centimeters. |
21 | $136 | $506 |
| Complex or multiple skin abscess drainage A procedure to drain one or more skin abscesses that are complex in nature. This involves opening and cleaning the infected pockets under the skin. |
18 | $179 | $342 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
18 | $33 | $92 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
16 | $106 | $395 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring 1.1 to 2.0 centimeters from the scalp, neck, hands, feet, or genitals. |
15 | $109 | $406 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
13 | $130 | $264 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$7,531
Total received (2018-2024)
Avg $1,076/year across 7 years
Top 19% in PA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
381
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,397
2023
$1,179
2022
$824
2021
$973
2020
$567
2019
$1,467
2018
$1,123
Payments by company (2024)
ABBVIE INC.
$215
Incyte Corporation
$161
Dermavant Sciences, Inc.
$132
Regeneron Healthcare Solutions, Inc.
$113
Novartis Pharmaceuticals Corporation
$104
UCB, Inc.
$103
ConvaTec Inc.
$89
E.R. Squibb & Sons, L.L.C.
$82
Ortho Dermatologics, a division of Bausch Health US, LLC
$79
SUN PHARMACEUTICAL INDUSTRIES INC.
$75
Arcutis Biotherapeutics, Inc.
$58
GENZYME CORPORATION
$39
PFIZER INC.
$36
Janssen Biotech, Inc.
$22
Amgen Inc.
$21
Genentech USA, Inc.
$18
Kyowa Kirin, Inc.
$18
Galderma Laboratories, L.P.
$17
Lilly USA, LLC
$15
Top 3 companies account for 36.4% of 2024 payments
All-time payments by company (2018-2024) ›
Merz North America, Inc.
$877
AbbVie Inc.
$679
ABBVIE INC.
$521
Incyte Corporation
$466
UCB, Inc.
$451
PFIZER INC.
$394
Celgene Corporation
$367
Regeneron Healthcare Solutions, Inc.
$366
GENZYME CORPORATION
$358
Novartis Pharmaceuticals Corporation
$302
Lilly USA, LLC
$280
AbbVie, Inc.
$220
Dermavant Sciences, Inc.
$191
Janssen Biotech, Inc.
$190
Ortho Dermatologics, a division of Bausch Health US, LLC
$145
LEO Pharma Inc.
$135
SUN PHARMACEUTICAL INDUSTRIES INC.
$130
Sun Pharmaceutical Industries Inc.
$120
E.R. Squibb & Sons, L.L.C.
$119
Galderma Laboratories, L.P.
$115
Amgen Inc.
$109
Mayne Pharma Inc.
$103
Genentech USA, Inc.
$101
Mission Pharmacal Company
$95
ConvaTec Inc.
$89
Lumenis, Inc
$84
NOVARTIS PHARMACEUTICALS CORPORATION
$79
Arcutis Biotherapeutics, Inc.
$58
MAYNE PHARMA INC.
$56
Biofrontera Inc.
$56
DUSA Pharmaceuticals, Inc.
$46
Kyowa Kirin, Inc.
$42
DERMIRA, INC.
$36
Helsinn Therapeutics (U.S.), Inc.
$27
Almirall LLC
$24
CONMED Corporation
$23
Taro Pharmaceuticals USA, Inc.
$18
Verrica Pharmaceuticals Inc.
$17
Journey Medical Corporation
$15
Sensus Healthcare, Inc.
$13
EPI Health, LLC
$13
Top 3 companies account for 27.6% of all-time payments
Associated products mentioned in payments ›
0.25% · AKLIEF · ALTRENO · AMELUZ · Absorica LD · Ameluz · Avar · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · Bimzelx · COSENTYX · Cabtreo · Cimzia · DORYX · DUOBRII · DUPIXENT · ENSTILAR · EPIDUO FORTE · EUCRISA · Enbrel · Erivedge · HUMIRA · HYLATOPIC · HYLATOPIC EMOLLIENT · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · INNOVAMATRIX AC · Ilumya · LEVULAN KERASTICK · LIBTAYO · Lumenis Pulse 120H · OPZELURA · Otezla · Ovace · PICATO · Poteligeo · QBREXZA · REMICADE · RINVOQ · SKYRIZI · SOOLANTRA · Seysara · Skyrizi · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · Tremfya · VALCHLOR · VISICLEAR · VTAMA · WYNZORA · Winlevi · XEOMIN · YCANTH · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
649
County median income
$123,041
Nearest hospital to ZIP centroid (approximate)
PAOLI HOSPITAL
4.5 mi
4.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Schafrank is a clinical cardiology specialist, with above-average Medicare volume (top 2% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Schafrank experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Schafrank performed 4,650 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Schafrank receive payments from pharmaceutical companies?
Yes. Dr. Schafrank received a total of $7,531 from 41 companies across 381 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schafrank's costs compare to other opticians in Wayne?
Dr. Schafrank's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schafrank) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Wayne
Browse opticians in Wayne ranked by procedure volume and transparency data.
Highest volume
Top Opticians in PA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in PA
Which PA opticians receive the most from drug and device companies.
By company
Merz North America, Inc. Payments to Doctors
See all physicians who received payments from Merz North America, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology